Drugs / BIIX 1 XX
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02198313 | Apr 1999 | — | Boehringer Ingelheim | Terminated | No outcome recorded |
| Phase 1 | NCT02198287 | Jan → Apr 1999 | — | Boehringer Ingelheim | Completed | No outcome recorded |
| Phase 1 | NCT02199873 | Jun → Sep 1998 | — | Boehringer Ingelheim | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BIIX 1 XX | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02198287 ↗ |
| Route | Inhaled | “BIIX 1 XX inhalation solution” NCT02198287 ↗ |